These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27349992)

  • 1. Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine.
    Piñero DP; Monllor B; Camps VJ; de Fez D
    J Optom; 2017; 10(2):135-138. PubMed ID: 27349992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Static perimetry in chloroquine retinopathy. Perifoveal patterns of visual field depression.
    Hart WM; Burde RM; Johnston GP; Drews RC
    Arch Ophthalmol; 1984 Mar; 102(3):377-80. PubMed ID: 6703984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
    Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
    Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatic-achromatic perimetry in four clinic cases: Glaucoma and diabetes.
    Cabezos I; Luque MJ; de Fez D; Moncho V; Camps V
    Indian J Ophthalmol; 2015 Feb; 63(2):146-51. PubMed ID: 25827546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxychloroquine Retinal Toxicity.
    Proano C; Kimball GP
    N Engl J Med; 2019 Apr; 380(17):e27. PubMed ID: 31018072
    [No Abstract]   [Full Text] [Related]  

  • 7. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine.
    Zhang S; Liu X; Cai L; Zhang J; Zhou C
    Lupus; 2019 Jan; 28(1):129-132. PubMed ID: 30428763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine, dosage parameters and retinopathy.
    Spalton DJ; Verdon Roe GM; Hughes GR
    Lupus; 1993 Dec; 2(6):355-8. PubMed ID: 8136818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maculopathy in patient with systemic lupus erythematosus treated with hydroxychloroquine.
    Rodríguez-Hurtado FJ; Sáez-Moreno JA; Rodríguez-Ferrer JM
    Reumatol Clin; 2012; 8(5):280-3. PubMed ID: 22481059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Monitoring patients on antimalarials: where are we now?
    Freund PR; MacDonald IM
    Can J Ophthalmol; 2013 Jun; 48(3):218. PubMed ID: 23769787
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: monitoring patients on antimalarials: where are we now? Author reply.
    Easterbrook M
    Can J Ophthalmol; 2013 Aug; 48(4):344. PubMed ID: 23931479
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring patients on antimalarials: where are we now?
    Easterbrook M
    Can J Ophthalmol; 2012 Dec; 47(6):465-70. PubMed ID: 23217497
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report.
    Abdel Galil SM
    Lupus; 2015 May; 24(6):638-40. PubMed ID: 25424894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SD-OCT As screening test for hydroxychloroquine retinopathy: The «flying saucer» sign].
    Asensio-Sánchez VM
    Arch Soc Esp Oftalmol; 2015 Jul; 90(7):338-40. PubMed ID: 25443193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.